#Japan #Tokyo #Shoko Trading #Hannong Chemicals #Pharmaceutical Additive

Shoko Trading Enters New Pharmaceutical Agreement with Hannong Chemicals

In May 2025, Shoko Trading Co., a leading comprehensive trading company based in Tokyo, Japan, will officially form a sales agreement with South Korean Hannong Chemicals (Hannong Chemicals Inc.), based in Anyang, Gyeonggi Province. This collaboration focuses on a new pharmaceutical additive called partially neutralized polyacrylic acid, set to hit the market in 2026.

The new additive is a water-soluble polymer designed to serve as a base for poultices and cooling sheets, essential in the pharmaceutical sector. With growing demand expected for these healthcare products, particularly in aging populations, sourcing from Hannong Chemicals is timely. The company is currently working on constructing a manufacturing plant, further supporting this venture.

Anticipated Benefits of the New Pharmaceutical Additive

Partially neutralized polyacrylic acid is significant due to its unique properties including adhesion and thickening capabilities. These features make it particularly suitable for use in poultices (commonly known as wet compresses) and cooling sheets. As the demographics in various regions age, the need for such health-focused products will likely rise. Furthermore, these cooling sheets will appeal to consumers looking for solutions for heat-related illnesses during the summer months or as a care option during fevers.

Sales Areas

Since 2016, Shoko Trading and Hannong Chemicals have maintained a solid trading relationship. Building on this, the sales agreement highlights both firms' confidence in the anticipated growth of the pharmaceutical additives market. Beginning in March 2026, Shoko Trading plans to act as the general distributor, particularly targeting East Asia and Southeast Asia where demand for poultices and cooling sheets is expected to soar.

Hannong Chemicals’ Entry into the Pharmaceutical Market

In addition to the newly introduced polyacrylic acid additive, Hannong Chemicals envisions producing carboxyvinyl polymers designated for pharmaceutical use, further diversifying their portfolio and market impact. Shoko Trading is committed to collaborating closely with Hannong Chemicals to maximize sales in this blossoming pharmaceutical market.

For inquiries regarding this new product, please contact Shoko Trading Co.

About Shoko Trading Co.

• - Name: Shoko Trading Co., Ltd.
• - Address: 31st Floor, Tamachi Station Tower N, 3-1-1 Shibaura, Minato-ku, Tokyo, Japan.
• - CEO: Kentaro Watanabe
• - Established: May 1947
• - Overseas Locations: China, South Korea, Taiwan, Thailand
• - Website: Shoko Trading

This significant deal marks an expansion in the capabilities and offerings of both companies in the competitive pharmaceutical industry. As the production gets underway, the anticipation for the new product lines continues to build, reflecting the increasing global focus on healthcare solutions.